Alexandria Real Estate Equities
ARE
$119.00
Share price
2.32%
Change (1 day)
5.90%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Earnings for Alexandria Real Estate Equities (ARE)
Earnings in 2023 (TTM): $0.35 B
According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings (TTM) are $0.47 B. In 2022 the company made an earning of $0.76 B a decrease over its 2021 earnings that were of $0.79 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Alexandria Real Estate Equities from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $0.35 B | -53.56% |
| 2022 | $0.76 B | -3.96% |
| 2021 | $0.79 B | -20.26% |
| 2020 | $0.99 B | 72.88% |
| 2019 | $0.57 B | 3.11% |
| 2018 | $0.56 B | 73.54% |
| 2017 | $0.32 B | 464.88% |
| 2016 | $57.15 M | -77.32% |
| 2015 | $0.25 B | 36.31% |
| 2014 | $0.18 B | -10.81% |
| 2013 | $0.20 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $0.89 B | 85.52% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | 1,476.06% | 🇺🇸 USA |
 Amgen AMGN | $4.34 B | 805.70% | 🇺🇸 USA |
 Gilead Sciences GILD | $1.07 B | 123.66% | 🇺🇸 USA |
 Illumina ILMN | -$1.08 B | -323.66% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | -1,318.57% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.2 B | -141.11% | 🇺🇸 USA |